IDStewardship

OCTOBER 3, 2024

Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 30 September 2024 I recently had the honor to give a key note speech for my alma matter, Northeastern University in Boston, MA. It took me a while to put the thoughts together and I had some support from my friend Dr. Robert Kraljevich. It seems like other people might potentially benefit from reading this and learning from my 20 years of experience in the pharmacy biz… so I put it on this webpage!

130

130

Drug Topics

OCTOBER 3, 2024

The Heart Failure Society of America 2024 Annual Meeting featured presentations exploring the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) for patients with heart failure.

Hospitals 131

Hospitals 131

STAT

OCTOBER 3, 2024

In the delivery room, time is everything. When I care for a patient experiencing an obstetric emergency, a few minutes can mean the difference between life and death. A pregnant uterus receives 700 milliliters of blood per minute leading up to delivery, and the same amount can be lost each minute if a postpartum hemorrhage is not adequately treated immediately after being recognized.

Controlled Substances 145

Controlled Substances 145

Fierce Healthcare

OCTOBER 3, 2024

Another significant legal headache related to star ratings is on the table of the federal government just days before open enrollment begins. | One call center interaction is at the crux of a lawsuit UnitedHealthcare is bringing forward against the federal government because of a reduced star rating score.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 3, 2024

Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published Thursday. People with schizophrenia often “hear” voices and sounds even when there are none — up to 80% of people with the mental illness have auditory hallucinations.

125

125

Drug Topics

OCTOBER 3, 2024

Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.

112

112

pharmaphorum

OCTOBER 3, 2024

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

110

110

STAT

OCTOBER 3, 2024

Apple Watch may help keep people with Parkinson’s disease out of the hospital. That’s according to early data from a Kaiser Permanente pilot program. Since late 2023, Kaiser Permanente has been giving some of its Parkinson’s patients in California an Apple Watch app called StrivePD, developed by Rune Labs. The app uses the onboard sensors in the device to track tremors associated with the disease; dyskinesia, a side effect of medication; activity; sleep; and falls.

People Management 117

People Management Hospitals 117

Pharmacy Times

OCTOBER 3, 2024

Fedratinib is an orally available, small molecule inhibitor of JAK-2 approved for treatment of myelofibrosis.

131

131

STAT

OCTOBER 3, 2024

From its founding days, Carequality knew that overseeing the flow of sensitive patient information in U.S. health care would be a tricky business. But the data exchange nonprofit with a staff of five probably never imagined finding itself in the middle of one of the biggest, and ugliest, antitrust fights in recent memory.  On one side is one of its biggest and most influential users: the nation’s largest electronic health records vendor, Epic Systems.

117

117

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

OCTOBER 3, 2024

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an

FDA 115

FDA 115

STAT

OCTOBER 3, 2024

Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex , allowing the man with no limb movement to control objects using his thoughts, the brain-computer interface field looks dramatically different — both the people doing the research and the technologies they are creating.  Researchers like Leigh Hochberg and Eddie Chang and big-name startups such as Synchron and Paradromics have turned what was not too long ago an arcane academi

109

109

Fierce Healthcare

OCTOBER 3, 2024

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin. | Texas is suing drug manufacturers and the big three PBMs for insulin pricing tactics that adversely impacted the state's diabetes patients.

106

106

Fierce Pharma

OCTOBER 3, 2024

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, | Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have been producing copycat versions of the in-demand treatments.

Compounding Pharmacies 106

Compounding Pharmacies Compounding 106

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

OCTOBER 3, 2024

Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Vaccines 112

Vaccines Immunization 112

The Checkup by Singlecare

OCTOBER 3, 2024

While not quite as common as tension headaches, millions of people in the United States experience migraines. According to the journal JAMA , 17.1% of women report having migraine symptoms, with the majority of those women being between ages 20 and 50. As such, countless women experience migraines during pregnancy, and those often come with unpleasant symptoms that require treatment with medication, like Nurtec (rimegepant).

Hospitals 105

Hospitals FDA 105

Pharmacy Times

OCTOBER 3, 2024

Currently, Danon disease has a poor prognosis and does not have any pharmaceutical therapeutics for treatment or management.

FDA 118

FDA 118

Fierce Healthcare

OCTOBER 3, 2024

Four of the nation’s leading cancer centers are coming together to work on AI through a newly formed collaborative, the Cancer AI Alliance (CAIA). | Four leading cancer centers are leveraging their data resources and AI to gain ground on cancer.

101

101

Outsourcing Pharma

OCTOBER 3, 2024

SK Groupâs contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its small molecule and peptide manufacturing muscle in South Korea.

101

101

STAT

OCTOBER 3, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. This week Medicare regulators released a 79-page report on a pandemic-era home hospital program that allowed approved health systems to deliver inpatient care in people’s homes.

Hospitals 100

Hospitals 100

Drug Topics

OCTOBER 3, 2024

See what’s trending in pharmacy with a preview of the Drug Topics September/October issue.

112

112

Pharmacy Times

OCTOBER 3, 2024

As of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.

116

116

Fierce Pharma

OCTOBER 3, 2024

As officials consider how to distribute Eli Lilly’s Mounjaro to a nation that has a rapidly growing (PDF) o | As officials consider how to distribute Eli Lilly’s Mounjaro to a nation that has a rapidly growing obesity problem, England’s National Health Service is proposing that those who need it most should get it first.

95

95

Outsourcing Pharma

OCTOBER 3, 2024

The proceeds of the financing will support the development of LoQus23âs lead candidate, a small molecule inhibitor that is expected to enter the clinic in 2026.

98

98

Drug Topics

OCTOBER 3, 2024

This year’s meeting will take place from October 6 to 9 in Boston, Massachusetts.

112

112

pharmaphorum

OCTOBER 3, 2024

Proscia announces launch of Concentriq Embeddings and Proscia AI Toolkit, hoping to accelerate precision medicine R&D.

111

111

Pharmaceutical Technology

OCTOBER 3, 2024

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.

105

105

STAT

OCTOBER 3, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. Who gave up fishing on the Cape to run another biotech company? Read on today to find out.

87

87

Drug Topics

OCTOBER 3, 2024

Many public health officials aren’t surprised by the decline in vaccine coverage, although its underlying causes present unique challenges.

Vaccines 112

Vaccines 112

Pharmacy Times

OCTOBER 3, 2024

The Inflation Reduction Act's zero cost-sharing policy resulted in significant increases in shingles vaccines dispensed to individuals under Part D, compared with those who are commercially insured.

Vaccines 84

Vaccines Insurance 84

Pharmaceutical Technology

OCTOBER 3, 2024

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.

98

98

STAT

OCTOBER 3, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. When it comes to delivering shareholder value through M&A, Ron Renaud is a biotech investor’s best friend. Over the last 10 years, all three of the companies he has helmed were sold to Big Pharma for a combined $16 billion.

80

80

pharmaphorum

OCTOBER 3, 2024

A new report commissioned by ABPI found hospitals engaging in industry partnerships more likely to follow NICE recommendations.

Hospitals 95

Hospitals 95

Pharmacy Times

OCTOBER 3, 2024

Currently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.

Chemotherapy 73

Chemotherapy 73